In the last decades, a lot of attention has been paid to the compounds present in medicinal
Cannabis sativa L., such as Δ9‐tetrahydrocannabinol (Δ9‐THC) and cannabidiol (CBD) …

Drugs that target the endocannabinoid system are of interest as pharmacological options to
combat cancer and to improve the life quality of cancer patients. From this perspective …

“Medicinal cannabis” is defined as the use of cannabis-based products for the treatment of
an illness. Investigations of cannabis compounds in psychiatric and neurological illnesses …

Cannabis sativa L. is an important herbaceous species originating from Central Asia, which
has been used in folk medicine and as a source of textile fiber since the dawn of times. This …

Forest trees are a major source of biogenic volatile organic compounds (BVOCs). Terpenes
and terpenoids are known as the main BVOCs of forest aerosols. These compounds have …

β-Caryophyllene (BCP), a natural bicyclic sesquiterpene, is a selective phytocannabinoid
agonist of type 2 receptors (CB2-R). It isn't psychogenic due to the absence of an affinity to …

Fibromyalgia (FM) is a syndrome that does not present a well-defined underlying organic
disease. FM is a condition which has been associated with diseases such as infections …

Cannabis sativa (cannabis) produces a resin that is valued for its psychoactive and
medicinal properties. Despite being the foundation of a multi-billion dollar global industry …

Natural bicyclic sesquiterpenes, β‐caryophyllene (BCP) and β‐caryophyllene oxide (BCPO),
are present in a large number of plants worldwide. Both BCP and BCPO (BCP (O)) possess …

The CB 2 receptor is the peripheral receptor for cannabinoids. It is mainly expressed in
immune tissues, highlighting the possibility that the endocannabinoid system has an …